REALLY ? Look at the positions WP has held prior !!!! What WP is being paid is in keeping with the knowledge and experience he brings to the table . Don’t go banging this crap that it’s not within the range of what Australian CEO s get paid because he’s not . WP is a world class CEO , what he’s done to turn this company around is nothing short of amazing . If you can’t realise this quite frankly your not a astute investor and seem to have little knowledge of managing a company . I personally have . I have realised the potential of this company and what WP has bought to it to correct the issues holding it back . Over the last 2 years I have invested heavily in this company realising WP s change of direction in the company could possibly realise substantial returns . This company is finally going to see great returns for those smart enough to realise it’s potential , WP was the final piece of the jigsaw puzzle needed to make it happen . So do you really think 20 million is going to set up a successful global network to market Cardiocel ? As much as WP had hoped for it to succeed he realised two things needed (1) It gained ADAPT products recognition around the world , something needed for the TAVR project ( 2 ) It put the company in a position where Cardiocel could achieve a reasonable price at sale . Do you really this Cardiocel could have been sold for that much without gaining some traction in the market place ? As I said when WP took this company over the structure and direction of this company was appalling . Quite frankly I am sick of hearing people critical of what WP has been paid here and questioning his management . If this company had been managed by others 95% would have sent it into liquidation years ago leaving investors penny less . GLTATH
- Forums
- ASX - By Stock
- AVR
- "Toot Toot"
"Toot Toot", page-120
-
- There are more pages in this discussion • 320 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$17.91 |
Change
-0.090(0.50%) |
Mkt cap ! $344.2M |
Open | High | Low | Value | Volume |
$18.00 | $18.10 | $17.75 | $74.32K | 4.151K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 681 | $17.90 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$18.25 | 100 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 681 | 17.900 |
1 | 1 | 17.800 |
1 | 443 | 17.700 |
1 | 26 | 17.650 |
1 | 200 | 17.560 |
Price($) | Vol. | No. |
---|---|---|
18.250 | 100 | 1 |
18.300 | 150 | 1 |
18.500 | 43 | 1 |
18.690 | 550 | 1 |
18.750 | 143 | 1 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online